Study of COVID-19 DNA Vaccine (AG0302-COVID19)

NCT04527081 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AnGes, Inc.